The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

Nature Genetics

Volumn 36, Issue 10, 2004, Pages 1099-1104

  Bhende, Prasanna M ^a   Seaman, William T ^a   Delecluse, Henri Jacques ^b   Kenney, Shannon C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; TRANSCRIPTION FACTOR; BZLF2 PROTEIN, HERPESVIRUS 4, HUMAN; GLYCOPROTEIN; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CPG ISLAND; DNA BINDING MOTIF; DNA METHYLATION; EPSTEIN BARR VIRUS; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MOTIF; VIRUS GENE; VIRUS GENOME; BINDING SITE; CELL LINE; GENETICS; METABOLISM; PATHOGENICITY; SITE DIRECTED MUTAGENESIS;

HUMAN HERPESVIRUS 4;

BINDING SITES; CELL LINE; DNA METHYLATION; DNA, VIRAL; GENOME, VIRAL; GLYCOPROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; MUTAGENESIS, SITE-DIRECTED; VIRAL PROTEINS;

EID: 6944244957     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1424     Document Type: Article

References (30)

1. rd edn. (eds. B.N. Fields et al.) 2397-2446 (Lippincott-Raven, Philadelphia, 1996).
2. rd edn. (eds. B.N. Fields et al.) 2343-2396 (Lippincott-Raven, Philadelphia, 1996).
3. Chevallier-Greco, A. et al. Both Epstein-Barr virus (EBV) encoded transacting factors, EB1 and EB2, are required to activate transcription from an early EBV promoter. EMBO J. 5, 3243-3249 (1986).
4. Countryman, J. & Miller, G. Activation of expression of latent Epstein-Barr virus after gene transfer with a small cloned fragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82, 4085-4089 (1985).
5. Takada, K., Shimizu, N., Sakuma, S. & Ono, Y. Transactivation of the latent Epstein-Barr virus genome after transfection of the EBV DNA fragment. J. Virol. 57, 1016-1022 (1986).
6. Zalani, S., Holley-Guthrie, E. & Kenney, S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA 93, 9194-9199 (1996).
7. Ragoczy, T., Heston, L. & Miller, G. The Epstein-Barr virus Rta protein disrupts latency in B lymphocytes. J. Virol. 72, 7978-7984 (1998).
8. Farrell, P., Rowe, D., Rooney, C. & Kouzarides, T. Epstein-Barr virus BZLF1 transactivator specifically binds to consensus AP-1 site and is related to c-fos. EMBO J. 8, 127-132 (1989).
9. Chang, Y., Dong, D., Hayward, G. & Hayward, S.D. The Epstein-Barr virus Zta transactivator: a member of bZIP family with unique DNA-binding specificity and a dimerization domainthat lacks the characteristic heptad leucine zipper motif. J. Virol. 64, 3358-3369 (1990).
10. Flemington, E. & Speck, S. Evidence for coited-coil dimmer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc. Natl. Acad. Sci. USA 87, 9459-9463 (1991).
11. Adamson, A. & Kenney, S.C. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology 251, 187-197 (1998).
12. Feederle, R. et al. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19, 3080-3089 (2000).
13. Packham, G., Economou, A., Rooney, C.M., Rowe, D. & Farrell, P.J. Structure and function of the Epstein-Barr virus BZLF1 protein. J. Virol. 64, 2110-2116 (1990).
14. Ragoczy, T. & Miller, G. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J. Virol. 75, 5240-5251 (2001).
15. Adamson, A.L. et al. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74, 1224-1233 (2000).
16. Robertson, K. DNA methylation and chromatin- unraveling the tangled web. Oncogene 21, 5361-5379 (2002).
17. Bestor, T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9, 2395-2402 (2000).
18. Ernberg, I. et al. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J. Gen. Virol. 70, 2989-3002 (1989).
19. Paulson, E.J. & Speck, S.H. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J. Virol. 73, 9959-9968 (1999).
20. Robertson, K.D. & Ambinder, R.F. Methylation of the Epstein-Barr virus genome in normal lymphocytes. Blood 90, 4480-4484 (1997).
21. Masucci, M.G. et al. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. J. Virol. 63, 3135-3141 (1989).
22. Hendrich, B. & Bird, A.P. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538-6547 (1998).
23. Wade, P. Methyl CpG-binding proteins and transcriptional repression. Bioessays 23, 1131-1137 (2001).
24. Fuks, F. et al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278, 4035-4040 (2003).
25. Thompson, J.P., Granoff, A. & Willis, D.B. Trans-activation of a methylated adenovirus promoter by a frog virus 3 protein. Proc. Natl. Acad. Sci. USA 83, 7688-7692 (1986).
26. Herman, J.G., Graff, J.R., Myöhänen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: A novel PCR assay for methylation Status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-826 (1996).
27. Jenkins, P.J., Binne, U.K. & Farrell, P.J. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74, 710-720 (2000).
28. Liu, P. & Speck, S.H. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta. Virology 310, 199-206 (2003).
29. Adamson, A. & Kenney, S. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J. Virol. 73, 6551-6558 (1999).
30. Deng, Z. et al. The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation. Mol. Cell. Biol. 23, 2633-2644 (2003).